Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility Study of a Chatbot AI-Driven Preliminary Screening System for Hereditary Cancer Syndromes
Sponsor: National Cancer Centre, Singapore
Summary
This study aims to assess the feasibility of implementing an AI-based hereditary cancer preliminary screening system that has already been developed. This validation cohort will consist of healthy individuals and cancer patients, including those already suspected to be at risk of hereditary conditions.
Key Details
Gender
All
Age Range
21 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-07-21
Completion Date
2029-07-21
Last Updated
2026-10-28
Healthy Volunteers
Yes
Conditions
Interventions
Hereditary cancer preliminary screening chatbot
Patients will answer questions through the chatbot interface, which evaluates whether they meet HBOC, lynch syndrome, and Li-Fraumeni syndrome testing criteria based on their personal and family medical history. After using the system, a survey will be conducted among the study participants to assess the system's usability.
Locations (1)
National Cancer Center Singapore
Singapore, Singapore